Anti-Cancer Effect of Quercetin in Xenograft Models with EBV-Associated Human Gastric CarcinomaReport as inadecuate


Anti-Cancer Effect of Quercetin in Xenograft Models with EBV-Associated Human Gastric Carcinoma


Anti-Cancer Effect of Quercetin in Xenograft Models with EBV-Associated Human Gastric Carcinoma - Download this document for free, or read online. Document in PDF available to download.

1

College of Pharmacy, Duksung Women’s University, Seoul 132-714, Korea

2

Innovative Drug Center, Duksung Women’s University, Seoul 132-714, Korea

3

Department of Medicinal Crop Research, National Institute of Horticultural and Herbal Science, Rural Development Administration, Eumseong 369-873, Korea

4

College of Pharmacy, Research Institute of Pharmaceutical Sciences and Institute for Microorganisms, Kyungpook National University, Daegu 702-701, Korea





*

Authors to whom correspondence should be addressed.



Academic Editor: Jean Jacques Vanden Eynde

Abstract Licorice extracts have been widely used in herbal and folk medications. Glycyrrhiza contains diverse range of biological compounds including triterpenes glycyrrhizin, glycyrrhizic acid and flavonoids quercetin, liquiritin, liquiritigenin, glabridin, licoricidin, isoliquiritigenin. The flavonoids in licorice are known to have strong anti-cancer activities. Quercetin, the most abundant flavonoid, has been shown to have anti-ulcer, anti-cancer, antioxidant, and anti-inflammatory properties. Latent Epstein-Barr virus EBV infection can lead to serious malignancies, such as, Burkitt’s lymphoma, Hodgkin’s disease and gastric carcinomaGC, and Epstein-Barr virus associated gastric carcinoma EBVaGC is one of the most common EBV-associated cancers. In this study, the authors first examined the anti-cancer effects of quercetin and isoliquiritigenin in vivo xenograft animal models implanted with EBV+ human gastric carcinoma SNU719 or EBV− human gastric carcinoma MKN74, and then explored the molecular mechanisms responsible for their anti-cancer activities. The results obtained showed that anti-cancer effect of quercetin was greater than isoliquiritigenin in mice injected with EBV+ human gastric carcinoma SNU719 cells. On the other hand, quercetin and isoliquiritigenin had similar anti-cancer effects in mice injected with EBV− human gastric carcinoma MKN74 cells. Interestingly, quercetin inhibited EBV viral protein expressions, including EBNA-1 and LMP-2 proteins in tumor tissues from mice injected with EBV+ human gastric carcinoma. Quercetin more effectively induced p53-dependent apoptosis than isoliquiritigenin in EBV+ human gastric carcinoma, and this induction was correlated with increased expressions of the cleaved forms of caspase-3 -9, and Parp. In EBV−human gastric carcinoma MKN74, both quercetin and isoliquiritigenin induced the expressions of p53, Bax, and Puma and the cleaved forms of caspase-3 and -9 and Parp at similar levels. View Full-Text

Keywords: EBV; human gastric carcinoma; p53; quercetin; SNU719 EBV; human gastric carcinoma; p53; quercetin; SNU719





Author: Hwan Hee Lee 1,2, Seulki Lee 1,2, Yu Su Shin 3, Miyeon Cho 4, Hyojeung Kang 4,* and Hyosun Cho 1,2,*

Source: http://mdpi.com/



DOWNLOAD PDF




Related documents